Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of N-(1-hexahydroazepinylalkyl) acetamides for the treatment of cholinergic transmission disorders

Use of N-(1-hexahydroazepinylalkyl) acetamides for the treatment of cholinergic transmission disorders

US Patent 5200405 · Granted Apr 6, 1993

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molec2019
Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio) mole2017
Fluorogenic/fluorescent probes derivative from sulfoxanthene, and use thereof2016
7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetyl2016
Process of authentication for an access to a web site2015
7,11-methanocycloocta [B] quinoline derivative as highly functionalizable acetyl2015
Light-emitting biomarker2011
Benzo[b]chromeno-naphthyridin-7-one and pyrano[2′,3′:7,8]quino[2,3-b]quinoxalin-2010
Methods for treating glutamate cytotoxicity with beta-naphthoquinone compounds2009
Thiadiazine derivatives and use thereof as positive AMPA receptor modulators2009
Pyridopyrimidinone compounds, method for production thereof and medicaments comp2008
Substituted benzo[e][1,4]oxazino[3,2-g]isoindole compounds2007